mPGES-1 deletion impairs aldosterone escape and enhances sodium appetite

Am J Physiol Renal Physiol. 2010 Jul;299(1):F155-66. doi: 10.1152/ajprenal.90702.2008. Epub 2010 Mar 24.

Abstract

Aldosterone (Aldo) is a major sodium-retaining hormone that reduces renal sodium excretion and also stimulates sodium appetite. In the face of excess Aldo, the sodium-retaining action of this steroid is overridden by an adaptive regulatory mechanism, a phenomenon termed Aldo escape. The underlying mechanism of this phenomenon is not well defined but appeared to involve a number of natriuretic factors such prostaglandins (PGs). Here, we investigated the role of microsomal prostaglandin E synthase-1 (mPGES-1) in the response to excess Aldo. A 14-day Aldo infusion at 0.35 mg x kg(-1) x day(-1) via an osmotic minipump in conjunction with normal salt intake did not produce obvious disturbances in fluid metabolism in WT mice as suggested by normal sodium and water balance, plasma sodium concentration, hematocrit, and body weight, despite the evidence of a transient sodium accumulation on days 1 or 2. In a sharp contrast, the 14-day Aldo treatment in mPGES-1 knockoute (KO) mice led to increased sodium and water balance, persistent reduction of hematocrit, hypernatremia, and body weight gain, all evidence of fluid retention. The escaped wild-type (WT) mice displayed a remarkable increase in urinary PGE(2) excretion in parallel with coinduction of mPGES-1 in the proximal tubules, accompanied by a remarkable, widespread downregulation of renal sodium and water transporters. The increase in urinary PGE(2) excretion together with the downregulation of renal sodium and water transporters were all significantly blocked in the KO mice. Interestingly, compared with WT controls, the KO mice exhibited consistent increases in sodium and water intake during Aldo infusion. Together, these results suggest an important role of mPGES-1 in antagonizing the sodium-retaining action of Aldo at the levels of both the central nervous system and the kidney.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adaptation, Physiological
  • Aldosterone / administration & dosage*
  • Animals
  • Appetite Regulation* / genetics
  • Blood Pressure
  • Central Nervous System / metabolism*
  • Central Nervous System / physiopathology
  • Diet, Sodium-Restricted
  • Dinoprostone / urine
  • Drinking* / genetics
  • Epithelial Sodium Channels / metabolism
  • Gene Deletion
  • Hypernatremia / genetics
  • Hypernatremia / metabolism
  • Hypernatremia / physiopathology
  • Infusion Pumps, Implantable
  • Infusions, Subcutaneous
  • Intramolecular Oxidoreductases / deficiency*
  • Intramolecular Oxidoreductases / genetics
  • Kidney / metabolism*
  • Kidney / physiopathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Mice, Knockout
  • Plasma Volume
  • Prostaglandin-E Synthases
  • Receptors, Drug / metabolism
  • Sodium Chloride, Dietary / administration & dosage
  • Sodium Chloride, Dietary / metabolism*
  • Sodium-Hydrogen Exchanger 3
  • Sodium-Hydrogen Exchangers / metabolism
  • Sodium-Potassium-Chloride Symporters / metabolism
  • Solute Carrier Family 12, Member 1
  • Solute Carrier Family 12, Member 3
  • Symporters / metabolism
  • Time Factors
  • Water-Electrolyte Balance* / genetics
  • Weight Gain

Substances

  • Epithelial Sodium Channels
  • Receptors, Drug
  • Slc12a1 protein, mouse
  • Slc12a3 protein, mouse
  • Sodium Chloride, Dietary
  • Sodium-Hydrogen Exchanger 3
  • Sodium-Hydrogen Exchangers
  • Sodium-Potassium-Chloride Symporters
  • Solute Carrier Family 12, Member 1
  • Solute Carrier Family 12, Member 3
  • Symporters
  • Aldosterone
  • Intramolecular Oxidoreductases
  • Prostaglandin-E Synthases
  • Ptges protein, mouse
  • Dinoprostone